
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, advocates for increased research to find new and better therapies with which to treat patients with sarcoma
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, advocates for increased research to find new and better therapies with which to treat patients with sarcoma
New research suggests that exposure to dim light at night may cause breast cancer patients to become resistant to certain types of therapy.
The Prostate Cancer Foundation (PCF) has awarded 27 new Young Investigator Award selected from 16 countries to advance new drug discovery, immunotherapy, nutritional sciences, and diagnostics for precision medicine.
New research on the risk-reducing benefits of aspirin shed more light on its mechanism of action as well as its potential benefit to reduce the risk of aggressive prostate cancer
Researchers at Dana-Farber Cancer Institute noted that a number of survivorship care recommendations and templates for care plans exit but little is known about patients' preferences in survivorship care planning.
Patients in one phase III trial gained 2.4 pounds of lean body mass during 12 weeks of treatment with anamorelin, and those in the second trial had an average increase in lean body mass of 1.65 pounds.
FORCE is hosting two informative webinars in October for people affected by hereditary breast and ovarian cancer.
Academic medical centers and commercial genetics laboratories across the country have joined forces to establish the Prospective Registry Of Multi-Plex Testing (PROMPT), an online registry for individuals and families who have undergone testing for inherited cancer-causing genetic mutations.
The flu might just be an unwelcome nuisance for the average individual, but it can cause serious complications for cancer patients receiving treatment.
Lung cancer at any age is a catastrophic illness but it is particularly devastating when it affects young adults in the prime of their life.
Two active maintenance regimens following disease stabilization with standard induction therapy demonstrated superior disease-free outcomes compared with no treatment in patients with metastatic colorectal cancer
Many studies have found a link between regular exercise and a lower risk of being diagnosed with breast cancer or breast cancer coming back (recurrence). As a result, the American Cancer Society and many doctors recommend that women who've been diagnosed with breast cancer, as well as those who haven't, exercise regularly – about 4 to 5 hours per week at a moderate intensity level. (Brisk walking is considered moderate intensity exercise.)
Facing Our Risk of Cancer Empowered (FORCE), the nation's only nonprofit organization dedicated to families with hereditary breast and ovarian cancer (HBOC), is celebrating National Hereditary Breast and Ovarian Cancer Week and National Previvor Day to create awareness and recognize those affected by a genetic predisposition to these cancers.
A new study has confirmed that e-cigarettes are doing more harm than good when it comes to helping cancer patients quit smoking.
To address the question of whether axillary dissection is necessary in older women, researchers in Milan, Italy recruited 238 women aged 65-80 years with cT1cN0 breast cancer and randomized them to receive conservative surgery with or without axillary node dissection.
More than one-third of patients with breast or ovarian cancer or a family history of those diseases who also saw a genetic counselor did not pursue genetic testing for BRCA 1 or BRCA 2 mutations
Dr. Drew Pinsky's personal battle with prostate cancer inspires him to join forces with PCF
New patient-reported data presented at the 2014 ASTRO Annual Meeting has shown that Manuka honey is not more effective than standard medical care for the treatment of esophagitis pain during radiation therapy.
A new analysis of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial presented at the ASTRO 56th Annual Meeting offers substantial evidence that treatment with radiation therapy does not increase the incidence of lymphedema in patients with node-negative breast cancer.
A retired dentist and avid cyclist, Neil Dicker of Orefield, Pennsylvania is also a dedicated advocate for individuals affected by cutaneous lymphoma. In this video, Neil shares his inspiring story of living with the disease.
Does Medicare coverage for patients with cancer match up to what they actually want covered?
With the use of MRI imaging to restrict doses to erectile tissues, nearly half of men treated with external beam radiation therapy (EBRT) for prostate cancer were able to be sexually active without aids or medications 5 years later, and nearly 80% could be sexually active if such support was an option
A new study from Thomas Jefferson University suggests that observation may not be right for all patients with early stage prostate cancer.
That support is provided by matching people diagnosed with cancer and/or family members with trained volunteers who have themselves undergone and recovered from a similar cancer experience.
Radiotherapy is equally as effective in the palliation of dysphagia (difficulty swallowing) as chemoradiotherapy for patients with advanced esophageal cancer
In an "Art of Oncology" column in the Journal of Clinical Oncology, Nandita Khera, MBBS, MPH from the Mayo Clinic in Phoenix, AZ, proposes that financial toxicity is an important effect of cancer treatment that can be as devastating as other adverse medical events.
A study conducted by researchers at the Mayo Clinic has found that family conflicts and other nonmedical problems may raise their risk of complications following cancer surgery.
Please join us in Washington, DC, on September 20th for Cocktails for a Cure!
Show some heart! Register or donate to support the 2014 National Race to End Women's Cancer, Sunday, November 2 at the Freedom Plaza in Washington, DC.
The FDA has expanded the approval for the androgen receptor inhibitor enzalutamide (Xtandi) to include the treatment of men with chemotherapy-naive mCRPC.